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Abstract
Background: Studies on critical pathway use have demonstrated decreased length of stay and cost without
compromise in quality of care. However, pathway effectiveness is difficult to determine given methodological flaws,
such as small or single center cohorts. We studied the effect of critical pathways on total knee replacement
outcomes in a large population-based study.
Methods: We identified hospitals in four US states that performed total knee replacements. We sent a
questionnaire to surgical administrators in these hospitals including items about critical pathway use and hospital
characteristics potentially related to outcomes. Patient data were obtained from Medicare claims, including
demographics, comorbidities, 90-day postoperative complications and length of hospital stay. The principal
outcome measure was the risk of having one or more postoperative complications.
Results: Two hundred ninety five hospitals (73%) responded to the questionnaire, with 201 reporting the use of
critical pathways. 9,157 Medicare beneficiaries underwent TKR in these hospitals with a mean age of 74 years
(± 5.8). After adjusting for both patient and hospital related variables, patients in hospitals with pathways were 32%
less likely to have a postoperative complication compared to patients in hospitals without pathways (OR 0.68, 95%
CI 0.50-0.92). Patients managed on a critical pathway had an average length of stay 0.5 days (95% CI 0.3-0.6)
shorter than patients not managed on a pathway.
Conclusion: Medicare patients undergoing total knee replacement surgery in hospitals that used critical pathways
had fewer postoperative complications than patients in hospitals without pathways, even after adjusting for patient
and hospital related factors.
This study has helped to establish that critical pathway use is associated with lower rates of postoperative mortality
and complications following total knee replacement after adjusting for measured variables.
Background
In the past decade, health care has continued to be a
highly regulated environment with fixed reimbursement.
The demand is increasing for greater quality and effi-
ciency of heath care. For this reason, critical pathways
have gained tremendous popularity for hospital care
especially in the surgical arena. Critical pathways (also
known by other names such as clinical pathways, care
maps, and care paths) are plans of patient care that
delineate the sequence of actions necessary to achieve
optimal efficiency [1,2]. Critical pathways take many for-
mats, but often are incorporated into daily hospital pro-
gress notes either as multi-page forms with space for
documentation or as single pages used as checklists of
daily items. Despite widespread acceptance of critical
pathways for surgical procedures, there has been rela-
tively little rigorous evaluation of the effectiveness of
these critical pathways on outcomes [3-6].
Total knee replacement (TKR) presents an ideal model
to study the effect of critical pathways on patient out-
comes for several reasons. In general, joint replacement
is elective and it utilizes a standard treatment protocol
with well defined, measurable short-term outcomes. Sec-
ond, joint replacement patients are considered to be in
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fairly good health. Third, most joint replacement
patients are motivated to return to their usual daily
activities. Total knee replacement is one of the most
common orthopedic procedures performed and by 2030,
the demand for primary total knee arthroplasty may
reach greater than 3 million procedures [7].
Early studies on critical pathways and TKR demon-
strate a reduction in length of stay (LOS) of up to 57%,
and a trend towards decreased cost (savings up to
$4,091 per case) without compromise in quality of care
[6,8-15] More recent studies by Dy et al report that only
seven of 26 pathways used at large academic medical
centers have had the desired impact of lowering length
of stay [3]. This raises the issue of how critical pathways
perform not only within a single hospital but rather in
the “bigger picture” of healthcare across the nation.
Since the majority of critical pathway studies have
focused on length of stay and cost, the effect of critical
pathways on patient outcomes is unclear.
Consequently, there is a need for robust research with
larger patient samples to effectively examine critical
endpoints such as mortality and 90 day postoperative
complications. Early studies have not been powered to
examine these clinically important outcomes. Previous
studies have had numerous methodological limitations
including lack of controls or use of historical controls,
single hospitals with small samples, limited endpoints
such as length of stay rather than patient outcomes, and
failure to adjust for potential confounders that may
affect outcome [8-13,16,17]. In order to address these
gaps in the literature, the influence of critical pathways
on the postoperative outcomes of TKR across several
hundred hospitals in four states were examined. The
analyses adjusted for variables that may confound the
association between pathways and patient outcomes
including hospital procedure volume.
Methods
The data used in the paper were obtained from several
sources. Medicare claims data were obtained with a
Data Use Agreement with the Center for Medicare and
Medicaid Services (CMS). The hospital survey data were
obtained from by written surveys administered by our
research team to administrators at each participating
hospital. All of the data collection procedures were
approved by the Brigham and Women’s/Partners
HealthCare Human Investigation Committee.
Hospital Sample
Using Medicare claims data and previously published
algorithms, hospitals in four states were identified
(Ohio, Tennessee, North Carolina, and Illinois) that per-
formed at least one total knee replacement in the year
2000 [18]. These states were chosen to encompass
diverse geographic locations and a mix of urban and
rural areas. Data were collected on the use and imple-
mentation of critical pathways in each hospital using a
detailed survey that was sent to all the surgical
administrators.
The hospital survey contained seven questions about
characteristics of critical pathways used for TKR. (See
Below) Using information from a literature review and
expert consensus, a list of pathway characteristics were
identified that might affect pathway effectiveness. These
questions permitted classification of the hospitals into
three separate categories: no critical pathway used, par-
tial critical pathway used, and full critical pathway used.
List of critical pathway variables that were assessed
on the hospital questionnaire
• Uniformity of pathway use among surgeons: Did
pathways differ by surgeon?
• Development of clinical pathway: Institution speci-
fic or developed by an outside organization
• Critical pathway implementation:
• No pathway used
• Partial pathway in which the hospital used a
pathway but did not incorporate it in the medical
records
• Full pathway in which the hospital used it for
documentation in to the medical records
• Patient access to their pathway: Were they given a
copy of the pathway?
• Healthcare providers with specified tasks on the
pathway:
• Nursing
• Physical Therapy
• Social Work/care coordination
• Orthopedic surgeon
• Anesthesiologist
• Dietician
Patient Sample
The patient sample was comprised of Medicare benefici-
aries that had an elective total knee replacement in 2000
in hospitals that responded to our survey. Elective cases
of primary TKR were identified from Medicare Part A
(hospital) and Part B (outpatient and provider) claims
using specific surgical procedure and diagnostic codes.
The details of patient selection algorithm are described
elsewhere [18].
Hospital Level Data
In addition to using the hospital survey, data were used
from the 2000 AHA (American Hospital Association)
Annual Survey included the following: whether the hos-
pital was privately or publicly owned; located in a rural
Husni et al. BMC Musculoskeletal Disorders 2010, 11:160
http://www.biomedcentral.com/1471-2474/11/160
Page 2 of 7
or urban setting; a member of the Council of Teaching
Hospitals (’teaching hospital’) and the Joint Commission
on the Accreditation of Health Care Organizations
(JCAHO) status. Also data were identified for specific
hospital variables that could be associated with clinical
outcomes; these included hospital volume, surgeon
volume, nurse to patient ratio, and the teaching status
of the institution.
Medicare claims provided information on the proce-
dure volume. Hospital and surgeon volume as the total
number of primary and revision TKR performed by a
surgeon or a hospital in one year was defined. Hospital
volume was categorized into tertiles according to the
number of TKR procedures performed each year: less
than 50, 51-249, and greater than 250 procedures per
year. Surgeon volume was categorized into quartiles
according to the number of surgeons that operated for
total joint arthroplasty in that particular hospital.
Patient Level Data
Medicare claims data were used to ascertain patient out-
comes. These were defined as the occurrence of an
adverse event in the first 90 postoperative days including
death, myocardial infarction, pneumonia, pulmonary
embolus, and deep wound infection (requiring either
surgical debridement or removal of the prosthesis). Clin-
ical outcomes were based on diagnosis and procedure
codes of inpatient and physician Medicare claims. Medi-
care claims provided information on age, sex, and elig-
ibility for Medicaid (a surrogate for low income).
Comorbid illnesses were defined with an adaptation of
the Charlson comorbidity score [19-21].
Length of stay (LOS) was defined as the number of
days a patient stayed in the acute care hospital from the
date of TKR surgery to the date the patient was dis-
charged home or to a rehabilitation facility.
Statistical Methods
First, bivariate analyses were performed to evaluate
crude associations between the use of critical pathways
and each postoperative outcome. The principal outcome
was a composite dichotomous adverse event indicator
that was scored as positive if the patient had any one of
the following complications within 90 days of surgery:
mortality, myocardial infarction, pneumonia, pulmonary
embolus, and deep wound infection. A multivariable
logistic regression model was constructed to evaluate
the odds of a postoperative complication or death in the
pathway and non pathway groups, adjusting for patient
age, gender, co-morbidity index, Medicaid eligibility (a
proxy for poverty level income) and hospital volume.
Specific hospital variables that could potentially be asso-
ciated with clinical outcomes were assessed; these
included surgeon volume, JCAHO accreditation, and
presence of an orthopedic residency program, nurse to
patient ratio, and the teaching status of the institution.
The association between use of critical pathway and
outcome was expressed with an adjusted odds ratio.
Generalized estimating equations were used to adjust
for clustering within hospitals for all models [22]. A sen-
sitivity analysis was performed to further delineate
whether level of critical pathway implementation
affected outcome. The lengths of stay between those
patients with and without a critical pathway were also
examined.
Results
Hospital Sample
411 hospitals in Ohio, Tennessee, North Carolina, and
Illinois were approached. Six hospitals were excluded
due to mergers (3 hospitals) and closings (3 hospitals) in
2000 leaving 405 eligible hospitals. Of these, 295 (73%)
hospitals completed the survey, 29 (7%) hospitals
refused to participate while an additional 81 (20%) hos-
pitals did not respond to follow up letters or calls. (See
Figure 1) There was no statistically significant difference
in hospital characteristics between hospitals that
responded to the survey and those that did not in terms
of rural or urban setting, teaching status, or private or
public ownership. Of the 295 hospitals surveyed, 201
(68%) reported using a critical pathway for TKR surgery.
Patient Cohort: A total of 9,291 Medicare patients had
primary TKR at the hospitals that completed the survey.
134 patients were excluded due to missing information
on patient variables leaving 9,157 patients in the final
cohort. Patients on pathways differed slightly from
patients not on pathways in terms of Medicaid eligibil-
ity, a proxy for low income. In the non pathway group,
8.6% were eligible for Medicaid vs. 6.4% in the pathway
group (p value = 0.037). In both the critical pathway
and non critical pathway cohorts, mean age was 74
years, 31% were male, and > 30% had one or more co
morbidities. (See Table 1)
Description of pathway use
The majority of hospitals that used pathways developed
their own pathway (87%) while others either modified a
pathway from an outside source (7.8%) or used a path-
way from an outside source without (1.4%) modification.
We also queried whether patients were all managed on
the same pathway or different pathways for each sur-
geon; 60% of hospitals stated patients were managed on
the same pathway and 11% stated patients were mana-
ged by different pathways according to the surgeon.
About half or 55% of the hospitals stated they gave
patients a copy of the critical pathway during their hos-
pitalization. Almost all critical pathways had duties spe-
cific to nurses (100%), physical therapists (99%), social
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workers (90%), and dieticians (70%). (See Figure 2)
Interestingly, only a small percentage of pathways had
specific duties for physicians. For example, only 60% of
orthopedic surgeons and 34% of anesthesiologists had
specified duties on the critical pathways postoperatively
as compared with 100% for nurses and 99% for physical
therapists.
Primary analyses of the effect of pathway use on
outcomes
The primary analyses demonstrated that patients oper-
ated upon in pathway hospitals had a lower risk of post-
operative complications including death compared to
patients operated upon in hospitals without pathways.
Table 2 illustrates the results of logistic regression ana-
lyses, which controlled for socio demographic factors,
hospital and surgeon volume, and hospital teaching sta-
tus. The regression results showed a statistically signifi-
cant relationship between critical pathway use and a
lower risk of specific postoperative patient outcomes.
With the exception of infection, the odds ratios were
less than one ranging from 0.55 (95% CI 0.32-0.93) for
mortality to 0.66 (95% CI 0.43-1.02) for pneumonia
suggesting a protective effect of pathways on patient
outcome. Since the prevalence of postoperative
complications after TKR surgery is low, a composite
adverse event indicator was developed which scored
positive if the patient had any one of the adverse events.
These analyses showed that there were 32% fewer
adverse events in patients on critical pathways as
compared to those without a critical pathway (adjusted
OR = 0.68, 95% CI 0.50, 0.92).
Adjusted length of stay was an average of 0.5 days
(95% CI 0.3-0.6) shorter for patients on critical pathways
compared with patients without a critical pathway.
These analyses were adjusted for both patient level (age,
gender, Medicaid eligibility) and hospital level (hospital
volume, surgeon volume, hospital characteristics)
factors.
Additional analyses of pathway implementation strategies
Of the 201 hospitals using a critical pathway, the level of
implementation varied with 38% (76/201) of hospitals
using the partial critical pathway category (pathways
used but not incorporated into medical records), and
64% (128/201) of hospitals use the full critical pathway
category (pathways used and incorporated into medical
records). More detailed analyses were performed to
examine the effect of the level of critical pathway imple-
mentation. These analyses did not demonstrate an
Figure 1 Schema of hospitals and patients that participated in the study.
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association between level of pathway implementation
and patient outcomes with exception of pneumonia
(p-value for trend 0.006).
Discussion
The association between critical pathway use and 90 day
adverse event rates in a population based sample of
patients undergoing TKR was examined. The findings
indicate that postoperative complication rates were
lower in patients operated upon in hospitals that used
critical pathways compared to patients in hospitals with-
out critical pathways, suggesting a beneficial effect of
critical pathways on patient outcomes. Length of stay
was also shortened for those patients in hospitals that
used critical pathways by 0.5 days. To our knowledge,
this work on the effect of critical pathway use on TKR
outcomes represents the largest, most geographically
diverse, and comprehensive study of the outcomes of
critical pathways to date. Prior studies of critical path-
ways were limited by small samples, restriction to one
or a few referral centers, lack of controls, or the use of
historical controls limiting the ability to generalize and/
or introduced bias [4-6,24-26].
The finding of improved patient outcomes associated
with pathway use raises questions about the mechanisms
whereby critical pathways may affect outcomes. Do path-
ways increase the use of proven medical therapies for
patients? Do pathways ensure that organization and
delivery of care to each TKR patient is consistent? Do
pathways allow multidisciplinary teams to discuss each
patient with accountability? These questions cannot
satisfactorily be answered with our data but, raise these
issues to advance the understanding of critical pathways.
Key hospital characteristics that may have affected out-
comes, such as physical therapy availability and standar-
dization, specific discharge status, and orthopedic
operating room standards were not measured at the
patient level. Adjustments for patient demographics and
clinical characteristics were examined; these factors did
not change the finding that hospitals using pathways had
lower rates of complications. Given the positive associa-
tion of outcomes on patients following critical pathways,
future studies may benefit from emphasis on specific pro-
cesses of care that effect outcome. Future work on critical
pathways should expand outcomes to include quality of
life, satisfaction, and adherence to pathway management.
This study echoed results of previously published
papers reporting a shorter length of stay with patients
Figure 2 Percentage Compliance and Categories of Care in Hospitals with Critical Pathways.
Table 1 Characteristics of Patients and Hospitals With
and Without A Critical Pathway
Characteristics Critical
Pathway
N (%)
No Critical
Pathway
N (%)
P value
Patients 7,440 (81.2) 1,717 (18.8)
Age, mean (SD), years 74.3 (+/-5.8) 73.9(+/-5.7) NS
Gender, male 2,276(31) 535(31) NS
Number of comorbid illnesses
0 4680 (63) 1,116(65) NS
1 1741 (23) 378(22) NS
> 1 1019(14) 223(13) NS
Medicaid eligible 476(6.4) 149(8.6) p = 0.04
Adverse events
Death 40(0.5) 18 (1.1) p = 0.02
Acute myocardial infarction 59(0.8) 22 (1.3) p = 0.05
Pneumonia 102 (1.4) 37 (2.2) p = 0.02
Pulmonary embolus 58(0.8) 22 (1.3) p = 0.04
Deep wound infection 26 (.4) 6 (.4) NS
Hospitals Critical
Pathway
N = 204
No Critical
Pathway
N = 91
Length of Stay 5.8 (2.4) 5.3 (2.0) p = .00001
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on a critical pathway compared to those not on a critical
pathway as performed by an English language MED-
LINE search in April 2007 [1-8,12-14,26,27]. Even with
adjustment for patient demographics and hospital
volume, patients on a critical pathway had an average of
0.5 days shorter length of stay compared to those not
on a pathway. However, this difference of 0.5 days may
not be meaningful if in fact it was achieved at the
expense of increased rehabilitation stay for these
patients at another facility [4-26]. Further research
should be done to clarify whether pathways truly
decrease costs or simply shift them.
A pilot study was performed to better understand
pathways used by different institutions. Pathways from
40 hospitals were obtained in the sample and noted tre-
mendous variability in content and level of detail. For
example, pathway length ranged from 2 to 18 pages in
this sample of 40. However, the majority of critical path-
ways examined shared key elements including specific
process of care (specialized pre op teaching session, pre
specified schedule of patient care including physical
therapy, deep vein thrombosis prophylaxis, Foley urinary
catheter removal, and nursing care) and a multidisciplin-
ary approach including the use of specialty services such
as physical therapy, dieticians, and social workers and
discharge planning checklist. Most variations on critical
pathways were attributed to level of detail and number
of days to be followed. Some critical pathways
accounted for every action that could possibly occur in
the care process so that nurses can merely check off
boxes after each item was accomplished. Other critical
pathways accounted for pre operative day 1 or 2 leaving
the rest of the hospitalization to traditional, daily pro-
gress notes.
The main strengths of this study include its large
population based sample and ability to capture out-
comes assessed with standardized, previously validated
algorithms. Further, 90 day adverse events were irre-
spective of whether they occurred in the acute hospitals,
at a rehabilitation facility or at home. The analyses
adjusted for potential confounders including patient
characteristics and were simultaneously adjusted for
both hospital and surgeon volume. Adjustment was also
made for clustering of patients within hospitals.
An important limitation is that this study was cross
sectional. Thus, causality, such as whether pathways
lead to better outcomes or vice versa cannot be deter-
mined. The use of the Medicare database may also pre-
sent potential limitations. These include confining the
study to patients greater than 65 years of age. However,
more than two thirds of TKR procedures are generally
performed in people over the age of 65 [7]. In addition,
Medicare claims do not provide data on functional sta-
tus of the patient, an important outcome of TKR.
Finally, it would be useful to examine the effects of clin-
ical pathways implemented in the rehabilitation process
following TKR. This was beyond the scope of our data
and remains an important research priority.
In conclusion, this study has established that critical
pathway use is associated with lower rates of postopera-
tive mortality and complications following total knee
replacement after adjusting for measured variables.
Further study is required to address mechanistic ques-
tions raised by the current findings; to identify the
patient- provider, and system-level factors that drive this
effect. In the meantime, these data should be taken into
account by hospitals considering whether to implement
critical pathways for TKR.
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